Thomas Hach

Thomas Hach

Company: Novartis

Job title: Executive Director


Turning the Question Around: How Can Patients Support Precision Medicine? 4:00 pm

• The development of clinically meaningful and patient-relevant biosignatures can be a long and cumbersome process. When we include patients’ input from the start it may become easier and faster • The objective of predicting responders and non-responders may not always require the most complex and comprehensive biosignature but ultimately the optimised benefit-risk needs to…Read more

day: Day 2 Eve

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.